Joining the Board of Directors in 2015, Dr. Heather Wakelee is a longtime IASLC member and the current President-Elect. She has served as Chair of the Communications Committee and has worked for more than a decade on various program committees for the World Conference on Lung Cancer.
Dr. Wakelee is a Professor of Medicine in the Division of Oncology at Stanford University and is the faculty director of the Stanford Cancer Clinical Trials Office. She has authored or co-authored over 200 articles on lung cancer and other thoracic malignancies, including thymic malignancies, and is involved in dozens of clinical trials related to lung cancer therapy and diagnostics.
Her research focuses on specific lung cancer subtypes defined by mutations. She is also involved in trials of adjuvant therapy, immunotherapy and anti-angiogenesis agents in addition to collaborations with colleagues focused on biomarkers and population science research.
A graduate of Princeton University and Johns Hopkins University School of Medicine, Dr. Wakelee completed her post-graduate training at Stanford University.